Fifth Third Bancorp
PTCT icon

Fifth Third Bancorp’s PTC Therapeutics PTCT Stock Holding History

Fifth Third Bancorp’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
37,328
+19,881
+114% +$1.44M ﹤0.01% 1050
2026
Q1 		$1.19M Buy
17,447
+17,307
+12,362% +$1.23M ﹤0.01% 1519
2025
Q4 		$10.6K Buy
+140
New +$10.2K ﹤0.01% 2109
2016
Q1 		– Sell
-1,467
Closed -$48K – 2606
2015
Q4 		$48K Sell
1,467
-1,186
-45% -$34.9K ﹤0.01% 1397
2015
Q3 		$71K Buy
+2,653
New +$113K ﹤0.01% 1273
2015
Q2 		– Sell
-1,354
Closed -$82K – 2918
2015
Q1 		$82K Sell
1,354
-310
-19% -$18.9K ﹤0.01% 1270
2014
Q4 		$86K Buy
+1,664
New +$73.2K ﹤0.01% 1218

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Fifth Third Bancorp's PTCT Position: Q2 2026 in Review

Fifth Third Bancorp increased its PTC Therapeutics (PTCT) stake by 114% in Q2 2026, buying an estimated $1.44M and bringing the position to 37,328 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1050.

Fifth Third Bancorp first reported a position in PTCT in Q4 2014 and has held it in 7 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Fifth Third Bancorp held 37,328 shares of PTC Therapeutics worth $3.04M as of Q2 2026.
  • Fifth Third Bancorp bought 19,881 PTC Therapeutics shares in Q2 2026, an estimated $1.44M.
  • PTC Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1050 holding.
  • Fifth Third Bancorp first reported a position in PTC Therapeutics in Q4 2014 and has held it in 7 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.